ARCHIVES

New FDA Commisioner’s Top Priorities: FDAMA Implimitation, Agency’s Science

This article is from The Cancer Letter archive.

Vol. 25 No. 01 | January 8, 1999

Download PDF Visit The Full Archive

Related Articles

Michael Atkins Named Deputy Director at Georgetown Lombardi Cancer Center

March 2, 2012

In Brief: Outstanding Investigator Awards Draw 150 Letters Of Intent; Applications Due July 15

June 15, 1984

FDA says new tools needed to speed therapeutics development.

March 26, 2004

In Brief: New RFA, Program Announcements Coming Up Soon From BCDB for Radiation, Breast Cancer Studies

December 7, 1979

Professional Societies: AACR Awards Honor 8 Scientists, Clinicians

April 2, 1999

Cancer Control Budget Still $4 Million Short

January 28, 1977